Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Ran Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5414-0277; OpenAlex author ID A5101784988. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers

Papers 4

  1. Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. Co-author DOI 10.1016/j.canlet.2025.217583↗
  2. Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1568976↗
  3. The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway. Co-author DOI 10.4149/neo_2023_230614n310↗
  4. LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. First author DOI 10.1016/j.omtn.2021.07.004↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongkun Wang · 4 shared papers, 2021–2025 · strength 0.83
  2. Bo Chen · 3 shared papers, 2023–2025 · strength 0.70
  3. Xiaohua Jiang · 1 shared paper, 2025 · strength 0.27
  4. Xiaohua Jiang · 1 shared paper, 2025 · strength 0.24
  5. Xiaohua Jiang · 1 shared paper, 2023 · strength 0.19
  6. Ming Xu · 1 shared paper, 2021 · strength 0.13
  7. Bo Chen · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.